Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy

Diabetes Research and Clinical Practice

Volumn 50, Issue 3, 2000, Pages 195-202

  Matsumoto, A ^a,c   Iwashima, Y ^a   Abiko, A ^a   Morikawa, A ^b   Sekiguchi, M ^c   Eto, M ^d   Makino, I ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b ASAHIKAWA RED CROSS HOSPITAL   (Japan)

^c Sapporo General Hospital   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin converting enzyme; Diabetes mellitus; Gene polymorphism; Nephropathy; Proliferative retinopathy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ALBUMINURIA; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REFERENCE VALUES; SEQUENCE DELETION;

EID: 0033661751     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(00)00194-7     Document Type: Article

References (33)

1. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications
2. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus
3. Association analysis of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics
4. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM
5. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients
6. Association of ACE gene polymorphism and diabetic nephropathy?
7. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM
8. Angiotensin binding sites in bovine and human retinal blood vessels
9. Angiotensin II binding receptors in retinal and optic nerve head blood vessels
10. Angiotensin-converting enzyme in bovine, feline, and human ocular tissues
11. Ocular renin-angiotensin: Immunohistochemical evidence for the presence of prorenin in eye tissue
12. Renin, prorenin, and immunoreactive renin in vitreous fluid from eye with and without diabetic retinopathy
13. An ocular renin-anglotensin system. Immunohistochemistry of angiotensinogen
14. Anglotensin levels in the eye
15. Renin-containing muler cells of the retina display endocrine features
16. Neovascularization produced by angiotensin II
17. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo
18. Increased plasma inactive renin in diabetes mellitus: A marker of microvascular complications
19. Renin-angiotensin system components and endothelial proteins as markers of diabetic microvascular disease
20. Diabetic retinopathy: Can we modify its course?
21. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
22. Report on diabetes mellitus
23. Colorimetry of angiotensin-I converting enzyme activity in serum
24. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy
25. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase1)
26. A pitfall in the association study of ACE gene polymorphism
27. UK prospective diabetes study XV: Relationship of renin-angiotensin system gene polymorphism with microalbuminuria in NIDDM
28. Angiotensin I converting enzyme gene polymorphism in non-insulin-dependent diabetes mellitus
29. Angiotensin-converting enzyme DD genotpye in patients with ischemic or idiopathic dilated cardiomyopathy
30. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels
31. Histopathologic changes
32. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II